Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Revvity Content
Video
Unlocking New Cures: How Functional Genomic Screening Revolutionizes Drug Discovery
This episode explores revolutionizing drug discovery with genomic screening.
Industry Insight
Partnerships Provide Automated Library Preparation Solutions
We spoke to Amit Patel, product marketing director at PacBio, to learn more about PacBio Compatible, the new collaborations and what benefits they will bring to customers.
Industry Insight
Revolutionizing Newborn Screening Through Next-Generation Sequencing
A recent study has shown the clinical value of proactive, sequencing-based screening in apparently healthy newborns for medically actionable conditions. How might these findings impact the current NBS landscape and what does it mean to the healthcare system on the global level?
Article
Orthogonal Validation: A Means To Strengthen Gene Editing and Gene Modulation Research
From RNAi to CRISPR, there are several methods that researchers can use to manipulate gene function. This article explores how orthogonal validation – the synergistic use of different methods – makes genetic perturbation studies more robust.
How To Guide
Harness the Power of 3D Cell Model Imaging
This guide explores how researchers can make the most of the latest 3D imaging tools to generate high-quality, relevant results from their cell culture experiments.
How To Guide
A Guide to Cell Signaling in Cancer Development and Progression
This guide highlights some of the key pathways that are commonly dysregulated in cancer. It also explores how dysregulation can lead to pathogenesis with examples across a broad range of cell and tissue types.
Product News
Revvity Signals Software and Scitara Expand Strategic Relationship To Accelerate Laboratory Digital Transformation
Revvity announced that its Revvity Signals Software business has entered into a strategic relationship with Scitara – a leading global provider of cloud-based solutions for the scientific industry.
Product News
Revvity Accelerates NGS Library Prep With Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC
Revvity announced the launch of the Fontus™ Automated Liquid Handling Workstation, designed to deliver easier and faster workflows which enable better results for next generation sequencing (NGS) and diagnostic research applications.
Industry Insight
Failing Faster To Succeed Sooner in Drug Discovery
Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
Product News
Honeycomb Biotechnologies and Revvity Launch New Solutions To Expand the Frontiers of Single Cell Research
Honeycomb Biotechnologies and Revvity have announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology.
Advertisement
